Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

AACR Annual Meeting 2023

Home
The Jackson Laboratory at AACR 2023
Onco-Hu Studies

Onco-Hu Studies

Published Date March 24, 2023

Download PDF

Previous Video

FcRn model platform

The FcRn platform from The Jackson Laboratory mimics specific aspects of the human IgG physiology providing the ideal model platform to assess the pharmacokinetics (PK) of therapeutic antibody candida
Next Flipbook

In Vivo Evaluation of Bispecific T-Cell Engager Efficacy and Safety

Other content in this Stream

about 1 year ago
2023 AACR The use of PBMC humanized mice to test the efficacy and safety of antibody and cell-based cancer immunotherapeutics

Read Flipbook
about 1 year ago
2023 AACR Novel preclinical model for the evaluation of cytokine release syndrome in response to CD19xCD3 bispecific antibody in humanized m

Read Flipbook
about 1 year ago
2023 AACR A new tumor-bearing humanized mouse model to evaluate the efficacy of bispecific T cell engager and monoclonal checkpoint antibodi

Read Flipbook
about 1 year ago
2023 AACR Comparisons of Rituximab and CD19xCD3 BiTE antitumor response across multiple humanized NSG strains engrafted with human hematopoi

Read Flipbook
about 1 year ago
2023 AACR Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunother

Read Flipbook
about 1 year ago
2023 AACR Mouse models of cancer available from The Jackson Laboratory

Read Flipbook
about 4 years ago
Oncology - Preclinical Models and Services

Read Flipbook
about 1 year ago
FcRn model platform

The FcRn platform from The Jackson Laboratory mimics specific aspects of the human IgG physiology providing the ideal model platform to assess the pharmacokinetics (PK) of therapeutic antibody candida

Watch Video
about 1 year ago
In Vivo Evaluation of Bispecific T-Cell Engager Efficacy and Safety

Read Flipbook
about 1 year ago
PDX Models & Services

Read Flipbook
about 4 years ago
Syngeneic Tumor Studies

Read Flipbook
over 1 year ago
Model Generation Services

Our team of subject matter experts will design your new mouse model based on your research goals.

Read Flipbook
about 2 years ago
AACR 2022 Poster: Age-related Immunosenescence and Cancer Drug Toxicity and Efficacy in C57BL/6J Syngeneic Model

Read Flipbook
7 months ago
A MHC Class I & II Deficient Platform Humanized with PBMCs

JAX NSG-MHC I/II KO mice readily engraft tumors and human PBMCs, have delayed GvHD, and deliver translationally-relevant results for various research applications.

Read Flipbook
about 2 months ago
Humanized NSG Mouse Models

CD34 and PBMC humanized NSG mice are powerful preclinical models for studying the actions of immuno-modulators, either alone or in combination with other treatments.

Read Flipbook
over 1 year ago
JAX Consulting Advisory Services

Read Flipbook
about 2 years ago
Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.

Read Flipbook
about 2 years ago
A New Way to Study Cytokine Release Syndrome

In vivo CRS assays have the potential to simultaneously derisk and accelerate the process of bringing successful therapies to the patients who need them most.

Read Flipbook
about 3 years ago
Targeting Natural Killer Cell Activity with Humanized NSG IL-15 Mouse Model

The NEW cord blood CD34+ HSC humanized NSG-IL15 mouse enables efficacy research for compounds targeting human natural killer (NK) cell activity including antibody-dependent cellular cytotoxicity.

Read Flipbook
over 3 years ago
JAX Guide: Assessing Antibody Pharmacokinetics Using the JAX FcRn Platform

Read Flipbook

Return to Home